LH – Laboratory Corporation of America Holdings
LH — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
4
Margin Of Safety %
3
Put/Call OI Ratio
1.37
EPS Next Q Diff
0.34
EPS Last/This Y
7.46
EPS This/Next Y
1.44
Price
280
Target Price
311.19
Analyst Recom
1.59
Performance Q
6.22
Upside
-11.3%
Beta
0.88
Ticker: LH
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-06-02 | LH | 257.68 | 0.96 | 3.83 | 2794 |
| 2026-06-03 | LH | 258.92 | 0.97 | 24.92 | 2816 |
| 2026-06-04 | LH | 260.92 | 1.18 | 0.11 | 3122 |
| 2026-06-05 | LH | 265.12 | 1.11 | 2.38 | 3218 |
| 2026-06-08 | LH | 262.01 | 1.09 | 0.64 | 3240 |
| 2026-06-09 | LH | 271.33 | 1.08 | 0.13 | 3255 |
| 2026-06-10 | LH | 268.7 | 1.03 | 0.36 | 3332 |
| 2026-06-11 | LH | 265 | 1.03 | 1.14 | 3356 |
| 2026-06-12 | LH | 266.05 | 1.03 | 3.00 | 3361 |
| 2026-06-15 | LH | 265.03 | 1.03 | 0.27 | 3364 |
| 2026-06-16 | LH | 264.89 | 1.01 | 0.63 | 3394 |
| 2026-06-17 | LH | 259.35 | 1.01 | 20.75 | 3392 |
| 2026-06-18 | LH | 255.74 | 1.13 | 139.00 | 3592 |
| 2026-06-22 | LH | 254.37 | 1.12 | 10.97 | 2696 |
| 2026-06-23 | LH | 258.53 | 1.70 | 0.08 | 3598 |
| 2026-06-24 | LH | 265.14 | 1.65 | 0.29 | 3643 |
| 2026-06-25 | LH | 266.24 | 1.59 | 1.42 | 3721 |
| 2026-06-26 | LH | 271.51 | 1.38 | 0.25 | 3908 |
| 2026-06-29 | LH | 279.73 | 1.36 | 0.53 | 3935 |
| 2026-06-30 | LH | 280.01 | 1.37 | 0.78 | 3926 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-06-01 | LH | 256.86 | 10.0 | 46.1 | 18.00 |
| 2026-06-02 | LH | 256.70 | 10.0 | 59.0 | 18.00 |
| 2026-06-03 | LH | 259.02 | 10.0 | 65.4 | 18.00 |
| 2026-06-04 | LH | 261.01 | 10.0 | 68.3 | 18.00 |
| 2026-06-05 | LH | 265.10 | 10.0 | 80.4 | 18.01 |
| 2026-06-08 | LH | 261.96 | 10.0 | 49.4 | 18.01 |
| 2026-06-09 | LH | 271.18 | 10.0 | 101.8 | 18.01 |
| 2026-06-10 | LH | 268.63 | 10.0 | 52.0 | 18.01 |
| 2026-06-11 | LH | 265.18 | 10.0 | 48.5 | 18.01 |
| 2026-06-12 | LH | 266.11 | 10.0 | 66.3 | 18.01 |
| 2026-06-15 | LH | 265.00 | 10.0 | 58.0 | 18.01 |
| 2026-06-16 | LH | 264.72 | 9.7 | 61.5 | 18.00 |
| 2026-06-17 | LH | 259.49 | 9.7 | 40.6 | 18.00 |
| 2026-06-18 | LH | 255.88 | 9.7 | 44.0 | 18.00 |
| 2026-06-22 | LH | 254.32 | 9.7 | 53.3 | 18.00 |
| 2026-06-23 | LH | 258.59 | 9.7 | 77.8 | 18.00 |
| 2026-06-24 | LH | 265.14 | 9.7 | 87.8 | 18.00 |
| 2026-06-25 | LH | 266.38 | 9.7 | 64.9 | 18.00 |
| 2026-06-26 | LH | 271.48 | 9.7 | 81.3 | 18.00 |
| 2026-06-29 | LH | 279.75 | 9.7 | 93.9 | 18.00 |
| 2026-06-30 | LH | 280.00 | 9.7 | 61.4 | 18.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-06-02 | LH | -7.17 | -0.69 | 4.13 |
| 2026-06-03 | LH | -7.17 | -0.69 | 4.13 |
| 2026-06-04 | LH | -7.17 | -0.69 | 4.13 |
| 2026-06-05 | LH | -7.17 | -0.69 | 4.13 |
| 2026-06-08 | LH | -7.17 | -0.84 | 4.13 |
| 2026-06-09 | LH | -7.17 | -0.84 | 4.13 |
| 2026-06-10 | LH | -7.37 | -0.84 | 4.20 |
| 2026-06-11 | LH | -7.37 | -0.84 | 4.20 |
| 2026-06-12 | LH | -7.37 | -0.84 | 4.20 |
| 2026-06-15 | LH | -7.37 | -0.85 | 4.20 |
| 2026-06-16 | LH | -7.37 | -0.85 | 4.20 |
| 2026-06-17 | LH | -7.37 | -0.85 | 4.20 |
| 2026-06-18 | LH | -7.37 | -0.85 | 4.20 |
| 2026-06-22 | LH | -7.37 | -0.85 | 4.20 |
| 2026-06-23 | LH | -6.74 | -0.85 | 4.20 |
| 2026-06-24 | LH | -6.74 | -0.85 | 4.20 |
| 2026-06-25 | LH | -6.74 | -0.85 | 4.20 |
| 2026-06-26 | LH | -6.74 | -0.85 | 4.00 |
| 2026-06-29 | LH | -6.74 | -0.85 | 4.00 |
| 2026-06-30 | LH | -6.74 | -0.85 | 4.00 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
4.25
Avg. EPS Est. Current Quarter
4.77
Avg. EPS Est. Next Quarter
4.59
Insider Transactions
-6.74
Institutional Transactions
-0.85
Beta
0.88
Average Sales Estimate Current Quarter
3730
Average Sales Estimate Next Quarter
3774
Fair Value
288.61
Quality Score
69
Growth Score
69
Sentiment Score
97
Actual DrawDown %
4.7
Max Drawdown 5-Year %
-34.5
Target Price
311.19
P/E
24.81
Forward P/E
14.36
PEG
1.63
P/S
1.62
P/B
2.64
P/Free Cash Flow
16.59
EPS
11.29
Average EPS Est. Cur. Y
18
EPS Next Y. (Est.)
19.44
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
6.66
Relative Volume
1.23
Return on Equity vs Sector %
-17
Return on Equity vs Industry %
-0.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
61.4
◆
LH
Healthcare
$280.01
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
68.1
Range 1M
94.7%
Sup Dist
2.8%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
9.6%
EPS NY
8.2%
52W%
74.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+29.5% upside
Upside
+29.5%
Quality
69
MoS
3%
LH — P/E HistoricalDiagnostics & Research
Labcorp Holdings Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 71000
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. It also has a collaboration with Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
LH
Latest News
—
Caricamento notizie per LH…
stock quote shares LH – Laboratory Corporation of America Holdings Stock Price stock today
news today LH – Laboratory Corporation of America Holdings stock forecast ,stock prediction 2023 2024 2025
marketwatch LH – Laboratory Corporation of America Holdings yahoo finance google finance
stock history LH – Laboratory Corporation of America Holdings invest stock market
stock prices LH premarket after hours
ticker LH fair value insiders trading